Inflammation and benign prostatic hyperplasia.
Prostatitis, a histologic diagnosis, has evolved over the years to describe a clinical syndrome that was believed to be associated with prostatic inflammation. Similarly, benign prostatic hyperplasia (BPH), another histologic diagnosis, has evolved to describe a clinical syndrome believed to be associated with prostatic enlargement. Recent explorations of the interrelationships between these prostate-associated histologic and clinical conditions have generated much interest and excitement. This article describes these relationships and their impact on the management of, in particular, BPH.
Nickel
J Curtis
JC
Department of Urology, Queen's University, Kingston, Ontario, Canada. jcn@queensu.ca
D015415:Biomarkers; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000145:classification / Q000209:etiology / Q000473:pathology*; D011472:Prostatitis / Q000145:classification* / Q000209:etiology / Q000473:pathology*
D015415:Biomarkers